AVITA Medical, Inc.RCELNASDAQ
LOADING
|||

Analyst Sentiment

Analysts lean bullish — 57% recommend buying.

Consensus Rating
Buy
7 analysts·Limited coverage
57%
Rating Distribution
Strong Buy
00%
Buy
457%
Hold
343%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 17% above analyst consensus — significant downside expected.

Bear Case
$3.50
-17%
Consensus
$3.50
-17%
Bull Case
$3.50
+-17%
Price Range7 analysts
Low
Consensus
High
$3.50
$3.50
Current Target
Current Price
$4.24
Above Target
$0.74

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-0.95(4 analysts)
Actual
Estimate
Range (Low–High)
Stock Alarm Pro
Forward Growth Estimates (YoY)
FY2027
Rev+56.23%
EPS
FY2028
Rev+142.47%
EPS
FY2029
Rev+26.11%
EPS+25.45%

Earnings Surprises

Beat rate:25%(3/12 quarters)
Avg surprise:-30.6%
Beat
Miss
Inline
Estimate
Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 16, 2026Lake Street
Avita Medical price target raised to $3.50 from $3 at Lake Street
Target:$3.50
-2.6%from $3.60
Oct 17, 2025Lake Street
Avita Medical downgraded to Hold from Buy at Lake Street
Target:$4.00
-25.7%from $5.38
Jan 8, 2025Lake Street
Avita Medical price target lowered to $14 from $20 at Lake Street
Target:$14.00
-0.4%from $14.06
May 14, 2024Piper Sandler
Piper Sandler Downgrades Avita Medical Ltd. (RCEL) to Neutral
Target:$9.00
+7.8%from $8.35